Drug Shortage Report for TEVA-FAMOTIDINE
Report ID | 94880 |
Drug Identification Number | 02022141 |
Brand name | TEVA-FAMOTIDINE |
Common or Proper name | TEVA-FAMOTIDINE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FAMOTIDINE |
Strength(s) | 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-09-26 |
Estimated end date | 2020-03-31 |
Actual end date | 2020-03-09 |
Shortage status | Resolved |
Updated date | 2020-03-10 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-09-26 | English | Compare |
v1 | 2019-09-26 | English | Compare |